Gene Query: GINS4

Dataset Description Geneva Score
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 58.27
TCF7L1 knockdown in pancreatic cancer 48.32
The regulartory role of ZCCHC24 in splicing machinery 35.05
GATA3-mediated chromatin reprogramming in breast cancer cells 32.1
Transcriptome analysis of U87 cells upon LINC00152 knockdown 30.98
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 25.72
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 25.32
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 23.52
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 22.8
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 22.74
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 22.25
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 22.25
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 21.08
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 21.05
Genome-wide chromatin analysis of Ewing sarcoma 21.05
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 20.81
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 20.81
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 20.6
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 19.31
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 19.31
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 19.31
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 18.59
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 18.53
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 18.12
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 18.1
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 16.73
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 16.73
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 16.64
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 16.2
Global gene expression profile of dasatinib-resistant RCH-ACV cells 16.19
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 16.12
Transcription control by the ENL YEATS domain in acute leukemia 16.12
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 16.01
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 16.01
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 15.8
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 15.57
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 14.75
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 14.69
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 14.18
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 14.11
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 13.98
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 13.46
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 13.33
Total RNA-seq in ALL-SIL upon JQ1 inhibition 12.97
Analysis of transcriptional regulation by Myt1 and Myt1l 12.74
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 12.59
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 12.59
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 12.42
Human HAP1 cells before and after nutrient deprivation 12.23
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 12.23
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 12.17
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 11.69
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 11.69
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 11.49
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 11.46
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 11.35
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 11.14
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 11.14
Genome-wide transcriptional response to random aneuploidy in human cells 11.07
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 10.96
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  10.76
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.76
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 10.63
Exploring ILF2 regulatory genes by next-generation sequencing 10.55
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 10.26
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 10.26
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 10.19
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 10.17
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.13
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.01
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 9.67
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 9.66
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 9.66
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.59
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.59
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.42
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.31
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.17
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.17
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 9.1
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 9.05
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 9.05
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 9.01
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.97
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.89
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 8.8
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 8.79
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 8.65
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 8.61
Tracking of dCas9-methyltransferase footprints 8.53
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 8.53
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.4
Identification of Sin3B regulated genes during quiescence 8.31
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 8.29
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.2
FOXD3 is a novel tumor suppressor in lung cancer 8.18
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 8.16
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 8.13
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 8.1
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 8.08
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 8.04
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 7.97
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 7.92
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.86
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.85
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.85
Effect of CHKA knockdown on C4-2 cell transcriptome 7.82
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 7.71
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.69
p53 activity results in DNA replication fork processivity 7.64
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 7.62
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 7.6
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.6
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.56
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.56
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 7.56
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 7.55
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 7.55
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.52
Gene expression analysis of dengue-infected cells 7.52
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.5
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 7.38
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.36
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.36
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 7.33
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.26
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.22
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.13
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 7.11
A549 cells and MSR-A549 cells 7.08
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.08
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.07
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.07
MYCi361 regulates MYC target genes 7.06
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 7.04
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.03
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 7.01
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.97
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 6.97
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.93
Differentially expressed genes post knock down of lincDUSP26 6.91
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 6.89
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.65
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.63
High-efficiency RNA-based reprogramming of human primary fibroblasts 6.61
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.61
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 6.6
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 6.59
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 6.58
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.53
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.52
RNA-seq analysis of RALD iPSCs after in vitro differentiation 6.51
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 6.44
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 6.37
Gene induction by the USP6 oncogene in response to interferon 6.34
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 6.29
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 6.28
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 6.26
Identification of global regulators of T-helper cell lineage specification 6.26
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 6.26
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.25
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.23
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.23
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.22
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.2
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.19
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.18
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.18
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.15
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.15
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 6.15
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 6.12
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 6.12
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 6.09
Engineering Patient-Specific Tissue Implants 6.09
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.99
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.96
Effect of Hotair overexpression in human breast cancer cell lines 5.86
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.84
RNA-seq of shEZH2 cells 5.8
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 5.79
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 5.74
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.71
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.68
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 5.68
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.65
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.65
RIG-I and MDA5 fRIP during KSHV lytic reactivation 5.63
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 5.63
Effect of mitochondria deficiency on senescence-associated gene expression 5.6
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.58
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 5.57
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 5.57
Crizotinib v. DMSO in SW480 cells 5.51
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 5.49
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.48
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.47
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.46
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.46
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 5.46
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.46
RNAseq Analysis in glioblastoma cells treated with Mepazine 5.43
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.41
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.41
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.36
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 5.29
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.29
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 5.29
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 5.29
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 5.28
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.26
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.24
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.23
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.23
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.22
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.22
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.21
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.21
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.18
Inhibition of TNBC metastasis by Gpx1 5.17
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.16
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.16
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 5.14
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 5.14
Co-transcriptional loading of RNA export factors shapes the human transcriptome 5.13
RNAseq of HEK293 cells after Chtop knockdown 5.13
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 5.12
hnRNP C is a key regulator of protein synthesis in mitosis 5.11
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 5.11
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.1
UV_24h_GRO-Seq 5.08
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.08
Genome-wide analysis of Dengue virus 2 infected cells 5.07
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.06
Effect of Influenza virus infection on lncRNA expression in A549 cells 5.05
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 5.03
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.02
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.02
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 5.01
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 5.01
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 5.01
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 5.0
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.97
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.97
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.97
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.96
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 4.94
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.94
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 4.92
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 4.92
Ribosomal footprinting of CN34-Parental and CN34-LM1a 4.87
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.85
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.83
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 4.82
Chromatin landscape of human visceral and subcutaneous adipocytes 4.81
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 4.81
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 4.81
RNA-seq analysis of AML cells in response to ASLAN003 4.8
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 4.76
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.73
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 4.71
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.7
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.68
Transcriptomic analyssis following EHMT1/2 inhibition 4.68
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 4.67
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.67
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.65
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.63
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.6
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.59
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.58
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.58
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.58
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 4.57
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 4.56
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.51
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.48
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.47
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.42
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.41
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.41
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.39
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.38
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.37
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.37
LNCaP treated with iBET 4.33
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.3
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.27
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.26
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 4.25
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.25
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.22
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.2
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 4.17
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.16
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.1
SNHG5 siRNA knock down in HCT116 cells 4.08
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.07
RNA-seq analysis of differentiating human erythroblasts 4.07
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 4.06
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.04
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.03
Mitochondrial dsRNA triggers antiviral signalling in humans 4.02
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 4.02
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.01
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.98
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.97
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.93
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.93
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.89
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 3.85
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 3.81
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.8
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.8
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.79
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 3.78
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 3.78
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.77
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.71
Transcriptome-wide identification of CELF2 functional targets in T cells 3.7
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.67
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.65
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.63
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.63
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.63
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.61
CD86 regulates a pro-survival signal in myeloma cells 3.58
BACH2 in human plasma cell fate decision 3.5
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.47
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.46
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 3.44
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 3.43
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.41
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.34
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.32
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.31
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.31
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.27
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.27
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.27
Functional role of CPPED1 in trophoblasts. 3.26
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.22
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.2
Gene expression profile in breast cancer cell lines using RNA sequencing 3.19
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.13
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 3.11
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.09
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.08
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 3.07
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.06
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.04
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.04
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 3.03
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.02
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.02
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.98
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.98
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.97
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.93
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.89
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.87
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.87
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.86
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.86
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.85
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.84
MicroRNA-125a-5p overexpression in human macrophages 2.83
Derivation and differentiation of haploid human embryonic stem cells 2.83
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.83
HNRNPM-regulated splicing dependencies in prostate cancer 2.83
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.79
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.78
Ro60-knockout cells 2.75
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.73
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.73
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.62
MicroRNA targetome analysis during HCMV infection 2.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.52
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.52
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.51
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.46
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.45
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.45
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.43
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.39
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.38
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.35
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.31
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.31
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.29
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.29
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.28
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.27
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.2
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.19
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.19
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.12
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 2.11
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.11
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.11
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.09
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.09
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 2.08
Functional significance of the HIV-1 Tat signature amino acid residues 2.0
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.93
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.91
Role of FGFR1 in neuronal devlopment 1.9
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.9
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.87
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.82
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.82
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.8
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.78
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.76
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.74
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.61
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.58
Regulation of hypoxia-inducible factor activity by ZMYND8 1.54
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.52
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.49
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.47
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.45
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.42
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.37
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.34
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.33
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.33
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.33
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.31
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.3
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.3
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.28
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.25
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.25
CDK12 mediated transcriptional regulation in U2OS cells 1.1
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.08
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.08
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.06
Gene expression profile in breast cancer cells 1.06
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.05
Identification of long noncoding RNAs regulated by p53 1.04
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.03
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.03
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.03
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.0
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.96
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.92
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.91
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.91
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.88
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.86
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.86
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.86
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.84
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.84
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.83
The cohesin complex prevents Myc-induced replication stress 0.81
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.79
Myc activation coordinates gene transcription and protein translation responses 0.77
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.75
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.72
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.71
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.53
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.52
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.52
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.45
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.45
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.36
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.32
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.27
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.27
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.27
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.26
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.23
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.23
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.23
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.22
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.22
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.21
JAK dependent survival of ALK- ALCL 0.2
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.18
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.14
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.14
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.12
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.12
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.09
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.08
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.08
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.04
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.01
Gene expression changes due to PARP knockdown in human cells 0.01
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.0
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation